Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)
PROTECT Trial: Patient Related OuTcomes With Endeavor Versus Cypher Stenting Trial
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Listed as NCT00476957, this PHASE4 trial focuses on Ischemic Heart Disease and remains completed. Sponsored by Medtronic Cardiac Rhythm and Heart Failure, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
6 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Rhythm and Heart Failure
- Medtronic Vascular
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Maastricht, Netherlands